Search - tctmd.com

Displaying 1 - 20 of 604

Sort: Relevancy | Date

Oral Anticoagulation Alone Best for Stable CAD Patients With AF: Meta-analysis

News Daily News

Oral Anticoagulation Alone Best for Stable CAD Patients With AF: Meta-analysis

Yael L. Maxwell

March 12, 2026

Good News for Intravascular Imaging Continues at 5 Years: RENOVATE-COMPLEX-PCI

News Daily News

Good News for Intravascular Imaging Continues at 5 Years: RENOVATE-COMPLEX-PCI

March 10, 2026

PPCI Not Enough to Stave Off Acute MI Mortality, European Data Imply

News Conference News EAPCI 2026

PPCI Not Enough to Stave Off Acute MI Mortality, European Data Imply

February 23, 2026

Off Script with Tesfaye Telila

News Opinion Off Script

Why Interventionalists Must Work Toward Global Cardiovascular Equity

Tesfaye Telila, MD

February 17, 2026

IVUS, OCT Each Bring Something to the Table for PCI in Complex Lesions: Meta-analysis

News Daily News

IVUS, OCT Each Bring Something to the Table for PCI in Complex Lesions: Meta-analysis

January 20, 2026

Delays in STEMI Cardiogenic Shock Care Come at a Cost: DanGer Shock

News Daily News

Delays in STEMI Cardiogenic Shock Care Come at a Cost: DanGer Shock

January 15, 2026

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD

News Conference News AHA 2025

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD

November 13, 2025

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

News Conference News AHA 2025

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

Michael O'Riordan

November 12, 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

News Conference News TCT 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

November 03, 2025

News Industry News

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

October 29, 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

What’s Going to Be Hot at TCT 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

News Conference News ESC 2025

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

September 01, 2025

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

August 12, 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

TCTMD’s Top 10 Most Popular Stories for May 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2025

May 30, 2025

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

News Conference News EuroPCR 2025

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

Yael L. Maxwell

May 20, 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

Should We Be Looking for ‘Occlusion MI’ Rather Than STEMI?

News Features

Should We Be Looking for ‘Occlusion MI’ Rather Than STEMI?

May 19, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.